CLINICAL_TRIALS
trial_result
· 2016-06-22
Clinical Trial Update: Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy [Phase 2]
Summary
A Phase 2 clinical trial evaluating TAK-583 for diabetic peripheral neuropathy has completed, reporting efficacy and safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetic Neuropathies | Phase 2 | Status: COMPLETED